These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2006-005324-17 Influence of indometacin on reaction time, postural balance and obstacle avoidance in healthy subjects. not-yet-due
Completed, but no date, and reported results 2007-001151-19 Placebo controlled trial to evaluate the effect on pain and function of six months treatment doxycycline in established knee osteoarthritis bad-data
Ongoing 2009-013481-10 Pharmacokinetics of high dose Ropivacaine with and without epinephrine for combined femoral and sciatic nerve block in lower extremity surgery. A pilot study. not-yet-due
Ongoing 2010-023844-34 Effectiveness and safety of parecoxib in children undergoing scoliosis surgery compared to placebo: a double-blinded randomised controlled trial not-yet-due
Completed, but no date, and reported results 2012-001704-38 Effect of local anesthetic dose versus volume on block duration of single shot ultrasound-guided axillary brachial plexus block with mepivacaine Effect van dosis versus volume van mepivacaine op de... bad-data
Completed, but no date, and reported results 2013-001008-13 Fast-track rehabilitation protocol for Total Knee Arthroplasty: A Randomized Controlled Trial comparing Local Infiltration Analgesia with Femoral Nerve Block Fast track revalidatie protocol voor to... bad-data
Reported results 2014-003010-93 Pharmacokinetic Profile of Ropivacaïne after Periarticular Local Infiltration Analgesia for Primary Total Knee Arthroplasty Farmacokinetiek van ropivacaïne bij LIA voor TKP-operatie 2015-04-09 due-trials
Exempt 2015-002402-36 Pharmacokinetic Profile of Liposome Bupivacaine (Exparel®) after Perineural Admission in the Interscalene Groove for Primary Total Shoulder Arthroplasty. Farmacokinetiek van een single shot Exparel... not-yet-due
Reported results 2016-002908-15 REDO study: RhEumatoid arthritis REtreatment with ultra-low dose Rituximab: Disease Outcome after Dose Optimization REDO studie: Reumatoïde artritis herbehandeling met ultra lage dosis rituximab: z... 2019-03-25 due-trials
Not reported 2017-000180-32 Pharmacokinetic Profile of Ropivacaine after Periarticular Local Infiltration Analgesia for Primary Total Knee Arthroplasty Without the use of a Tourniquet. Farmacokinetiek van ropivacaïne, gebruik... 2018-02-12 due-trials
Completed, report not yet due 2018-002362-39 Comparing Methotrexate monotherapy with methotrexate Plus LEflunomide combination ThErapy in Psoriatic Arthritis: A pragmatic randomized placebo-controlled double-blind clinical trial. Vergelij... 2021-06-30 not-yet-due
Reported results 2018-002641-11 The BRIDGE-PMR study: B-cell depletion with Rituximab for Dose reduction of Glucocorticoids: Efficacy in PolyMyalgia Rheumatica 2020-08-19 due-trials
Ongoing 2018-002822-22 US-guided Percutaneous needle tenotomy in Patients with Lateral Elbow Tendinopathy: A multicenter Randomized Controlled Trial Echografisch-geleide percutane naald tenotomie bij patiënten met latera... not-yet-due
Completed, report not yet due 2018-003432-72 Randomised controlled trial of dose reduction and withdrawal strategies of TNF inhibitors in Psoriatic Arthritis and Axial Spondyloarthritis. “Dose REduction Strategy Study of TNF inhibitors in Psoria... 2021-06-17 not-yet-due
Ongoing 2019-002413-18 The efficacy of Methotrexate for glucocorticoid dose reduction in recently diagnosed polymyalgia rheumatica patients: a double-blind randomized placebo controlled clinical trial. De effectiviteit ... not-yet-due
Ongoing 2019-002438-35 Multiple doses versus single dose of cefazolin to prevent periprosthetic joint infection after revision arthroplasty: a multicenter open-label, randomized clinical trial. Verlengde profylaxe versu... not-yet-due
Ongoing 2019-004101-27 INDIGO: Comparing pharmacokinetic parameters of golimumab 50 mg and golimumab 100 mg with a prolonged dose interval in patients with a rheumatic disease, a within-subject controlled study’ Het besc... not-yet-due
Ongoing 2020-002507-19 Comparison of subcutaneous and intravenous continued treatment with ultra-low dose Rituximab in rheumatoid arthritis: a randomised open-label non-inferiority trial Vergelijking tussen subcutane en ... not-yet-due
Ongoing 2020-005730-15 GOut TrEatment STrategy (GO TEST) FINALE study, a multicentre pragmatic randomized superiority trial of continuation versus cessation of urate lowering therapies in gout in remission. Het vergelijk... not-yet-due
Completed, report not yet due 2021-000710-42 The RTX-COVAC study: humoral response to COVID-19 vaccination after rituximab, and relation with dose and vaccination timing. A prospective cohort study. De RTX-COVAC studie: humorale response door... 2022-02-16 not-yet-due
Ongoing 2021-003679-32 Erector spinae plane block for reduction of early postoperative pain scores and opioid use in lumbar spinal fusion surgery, a prospective double-blinded randomized placebo controlled trial Erector ... not-yet-due